-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Poppy Eiodine Oil Injection This application increases arterial chemotherapy embolism therapy in patients with mid-stage hepatocellular carcinoma in adults with adaptive disorders.
application was accepted by the State Drug Administration in September 2020.
oil injections were first approved in the United States in March 1954 and are now available in several countries around the world.
china approved the import of iodized oil injections from The French company Garber in August 2001.
's poppy ethyl iodine oil injection is consistent with the main active ingredient of the original product, ethyl glycate for iodized poppy seed oil fatty acid, adaptive disease for the treatment of iodine deficiency disease, lymphatic oculation, was approved in September 2016, the approval code is "National Drug Code H20163348."
, global sales of the product will be approximately $47.43 million in 2019.
, the cumulative investment in research and development costs of the product is about 31.22 million yuan.